electroCore, Inc. (ECOR) vs Milestone Pharmaceuticals Inc. (MIST)
A side-by-side comparison of electroCore, Inc. and Milestone Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ECOR
electroCore, Inc.
$9.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MIST
Milestone Pharmaceuticals Inc.
$0.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ECOR vs MIST
growth of $100 · dividends reinvested · last 7yECOR -88.6% (-26.6%/yr)MIST -94.9% (-34.7%/yr)ECOR compounded faster over this window
ECOR MIST
ECOR vs MIST: by the numbers
- •MIST is the larger company ($95M vs $89M market cap).
- •Both run net losses; ECOR's is the smaller (-39.96% vs -3585.62% net margin).
- •ECOR grew revenue faster over the past five years (52.51% vs -31.02% CAGR).
Metrics side by side
Valuation
| Metric | ECOR | MIST |
|---|---|---|
| P/S ratio | 2.42 | 40.61 |
| P/B ratio | N/A | 5.22 |
Profitability
| Metric | ECOR | MIST |
|---|---|---|
| Gross margin | 87.06% | 94.58% |
| Operating margin | -37.64% | -4041.72% |
| Net margin | -39.96% | -3585.62% |
| ROE | N/A | -461.14% |
| ROIC | -217.73% | -49.27% |
Growth (annualized)
| Metric | ECOR | MIST |
|---|---|---|
| Revenue CAGR (5Y) | 52.51% | -31.02% |
| Total return CAGR (5Y) | -8.10% | -33.18% |
Frequently asked
- Which has grown faster, ECOR or MIST?
- Over the past five years, ECOR grew revenue faster — ECOR at a 52.51% CAGR versus MIST at -31.02%.
- How have ECOR and MIST total returns compared?
- Over the past 5 years, ECOR delivered -8.10% and MIST delivered -33.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
electroCore ROEMilestone Pharmaceuticals ROEelectroCore operating marginMilestone Pharmaceuticals operating marginelectroCore revenue growthMilestone Pharmaceuticals revenue growthelectroCore free cash flowMilestone Pharmaceuticals free cash flow
electroCore & Milestone Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.